LAS VEGAS, NV, UNITED STATES, January 15, 2025 /EINPresswire / -- The Alopecia Areata market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period.
After the review concluded, warnings were added to the label of Xeljanz as well as two other oral JAK drugs for arthritis – Eli Lilly's Olumiant (baricitinib) and AbbVie's Rinvoq (upadacitinib ...